相关实验视频

Updated: Jan 15, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

脱发症的免疫疗法:证据和新的观点

Hui-Jun Lai¹, Zhi-Ming Ye¹, Si-Qi Chen¹

¹Guangdong Medical University, Zhanjiang, Guangdong, China.

Expert review of clinical immunology

|October 13, 2025

概括

脱发性白发症 (AA) 是一种由免疫系统功能障碍驱动的自身免疫性脱发症. 新的治疗方法侧重于向疗法和生物标志物,以改善患者的治疗结果,并超越慢性免疫抑制.

科学领域:

免疫皮肤学免疫皮肤学
自身免疫性疾病自身免疫性疾病
毛囊生物学毛囊生物学

背景情况:

脱发症 (AA) 是一种自身免疫性疾病,其特点是毛囊免疫特权崩.
疾病的进展涉及遗传因素,环境触发因素和免疫细胞相互作用 (树突细胞,CD4+,CD8+淋巴细胞).
关键的分子通路包括促炎性细胞因子 (IL-15,IFNγ) 和JAK-STAT信号级联.

研究的目的:

审查目前对AA病原和治疗景观的理解.
强调需要基于生物标志物驱动的患者分层.
探索未来超越传统免疫抑制的治疗策略.

主要方法:

对AA免疫学和治疗现有文献的审查.
分析当前的治疗方法,包括皮质类固醇,免疫抑制剂和新兴的向疗法.
讨论新的治疗点,如JAK抑制剂和免疫检查点调节器.

主要成果:

传统的治疗方法具有可变的疗效.
对T细胞活动 (Th1,Th2,Th17) 和免疫检查点的新兴见解正在指导新药的开发.
针对特定途径的JAK抑制剂和生物药物显示出有前途.

结论:

使用生物标志物的患者分层对于优化AA治疗选择和最小化风险至关重要.
未来的AA疗法可能包括将快速免疫抑制与免疫再生和耐受性诱导相结合.
目标是从慢性管理转向疾病修饰或治愈干预.

关键词:

阿洛佩西亚 areata 地区.雅克抑制剂的使用自身免疫性疾病是一种自身免疫性疾病.生物学的生物学.头发重新生长的方法免疫特权是一种特权.免疫耐受性免疫耐受性

更多相关视频

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...